Why the study?
Do SK channel blockers prevent hypoxia-induced ventricular arrhythmias in a rat model of cardiac hypertrophy?
Do SK channel blockers prevent hypoxia-induced ventricular arrhythmias in a rat model of cardiac hypertrophy?
SK channel activation via p-CaMKII contributes to action potential shortening and ventricular arrhythmias during hypoxia in hypertrophied hearts, suggesting SK channels as a potential therapeutic target.
SK channel blockade merits further preclinical study in hypertrophy; hypothesis-generating and should not yet inform clinical practice.
The molecular and electrophysiological mechanisms of acute ischemic ventricular arrhythmias in hypertrophied hearts are not well known. We hypothesized that small-conductance Ca 2+ -activated K + (SK) channels are activated during hypoxia via the Ca 2+ /calmodulin-dependent protein kinase II (CaMKII)-dependent pathway. We used normotensive Wistar-Kyoto (WKY) rats and spontaneous hypertensive rats (SHRs) as a model of cardiac hypertrophy. The inhibitory effects of SK channels and ATP-sensitive K + channels on electrophysiological changes and genesis of arrhythmias during simulated global hypoxia (GH) were evaluated. Hypoxia-induced abbreviation of action potential duration (APD) occurred earlier in ventricles from SHRs versus. WKY rats. Apamin, a SK channel blocker, prevented this abbreviation in SHRs in both the early and delayed phase of GH, whereas in WKY rats only the delayed phase was prevented. In contrast, SHRs were less sensitive to glibenclamide, a ATP-sensitive K + channel blocker, which inhibited the APD abbreviation in both phases of GH in WKY rats. SK channel blockers (apamin and UCL-1684) reduced the incidence of hypoxia-induced sustained ventricular arrhythmias in SHRs but not in WKY rats. Among three SK channel isoforms, SK2 channels were directly coimmunoprecipitated with CaMKII phosphorylated at Thr 286 (p-CaMKII). We conclude that activation of SK channels leads to the APD abbreviation and sustained ventricular arrhythmias during simulated hypoxia, especially in hypertrophied hearts. This mechanism may result from p-CaMKII-bound SK2 channels and reveal new molecular targets to prevent lethal ventricular arrhythmias during acute hypoxia in cardiac hypertrophy. NEW & NOTEWORTHY We now show a new pathophysiological role of small-conductance Ca 2+ -activated K + channels, which shorten the action potential duration and induce ventricular arrhythmias during hypoxia. We also demonstrate that small-conductance Ca 2+ -activated K + channels interact with phosphorylated Ca 2+ /calmodulin-dependent protein kinase II at Thr 286 in hypertrophied hearts.
No takes yet. Share an insight, caveat, or question.
Tenma et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: